Structure of the Roc–COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase

No abstract is available for this paper.

• Publication year

  2008

• Venue

  EMBO Journal

• Publication date

  2008-08-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/emboj.2008.150PMID 18650931PMCID PMC2519104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase

  2008influential reference
• The retinitis pigmentosa 2 gene product is a GTPase-activating protein for Arf-like 3

  2008cited by this paper
• The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation*

  2008cited by this paper
• Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1

  2007cited by this paper
• LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity.

  2007cited by this paper
• Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation.

  2007cited by this paper
• Structure of an ABC transporter in complex with its binding protein

  2007cited by this paper
• GTP binding is essential to the protein kinase activity of LRRK2, a causative gene product for familial Parkinson's disease.

  2007cited by this paper
• Structural insight into filament formation by mammalian septins.

  2007cited by this paper
• Leucine‐rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson’s disease R1441C/G mutants

  2007cited by this paper
• Structure of the small GTPase Rab27b shows an unexpected swapped dimer.

  2007cited by this paper
• The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity.

  2007cited by this paper
• Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.

  2007influential reference
• The R1441C mutation of LRRK2 disrupts GTP hydrolysis.

  2007cited by this paper
• Direct binding of α‐actinin enhances TRPP3 channel activity

  2007cited by this paper
• Genetics of Parkinson disease: paradigm shifts and future prospects

  2006cited by this paper
• Structure of a GDP:AlF4 complex of the SRP GTPases Ffh and FtsY, and identification of a peripheral nucleotide interaction site.

  2006cited by this paper
• How guanylate-binding proteins achieve assembly-stimulated processive cleavage of GTP to GMP

  2006cited by this paper
• The interferon-inducible GTPases.

  2006cited by this paper
• LRRK1 protein kinase activity is stimulated upon binding of GTP to its Roc domain.

  2006influential reference
• Dimerisation‐dependent GTPase reaction of MnmE: how potassium acts as GTPase‐activating element

  2006cited by this paper
• TBC-domain GAPs for Rab GTPases accelerate GTP hydrolysis by a dual-finger mechanism

  2006cited by this paper
• Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.

  2006cited by this paper
• Kinase activity of mutant LRRK2 mediates neuronal toxicity

  2006cited by this paper
• Structural Insights into HypB, a GTP-binding Protein That Regulates Metal Binding*

  2006cited by this paper
• Monitoring the real-time kinetics of the hydrolysis reaction of guanine nucleotide-binding proteins

  2005cited by this paper
• A common LRRK2 mutation in idiopathic Parkinson's disease.

  2005cited by this paper
• Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.

  2005cited by this paper
• Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.

  2005cited by this paper
• The structure of the TrmE GTP‐binding protein and its implications for tRNA modification

  2005cited by this paper
• Substrate twinning activates the signal recognition particle and its receptor

  2004cited by this paper
• Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

  2004cited by this paper
• Heterodimeric GTPase Core of the SRP Targeting Complex

  2004cited by this paper
• Coot: model-building tools for molecular graphics.

  2004influential reference
• Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

  2004influential reference
• Mechanism of Association and Reciprocal Activation of Two GTPases

  2004cited by this paper
• Roc, a Ras/GTPase domain in complex proteins.

  2003cited by this paper
• Automated structure solution, density modification and model building.

  2002cited by this paper
• Identification of four candidate cGMP targets in Dictyostelium

  2002cited by this paper
• 3D domain swapping: As domains continue to swap

  2002cited by this paper
• The Guanine Nucleotide-Binding Switch in Three Dimensions

  2001cited by this paper
• Triphosphate structure of guanylate‐binding protein 1 and implications for nucleotide binding and GTPase mechanism

  2000cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper
• Crystal structure of a small G protein in complex with the GTPase-activating protein rhoGAP

  1997cited by this paper
• Crystal structure of the GTPase-activating domain of human p120GAP and implications for the interaction with Ras

  1996cited by this paper
• Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants

  1993cited by this paper
• Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation

  1989cited by this paper
• ras genes.

  1987cited by this paper

• Well-Tempered Metadynamics Simulations Combined with Free Energy Landscape Analysis Uncover the Conformational Transition Pathway of the DYG Motif in LRRK2.

  2025cites this paper
• Parkinson’s Disease Associated with Mutations in the LRRK2 Gene: Approaches to Therapy

  2025cites this paper
• Strengths, Weaknesses, Opportunities, and Potential Threat Analysis of Targeting Leucine-Rich Repeat Kinase 2 for Parkinson's Disease Treatment: Status Quo and Quo Vadis.

  2025cites this paper
• CalDAG-GEFI acts as a guanine nucleotide exchange factor for LRRK2 to regulate LRRK2 function and neurodegeneration

  2024cites this paper
• Structural insights into the GTP-driven monomerization and activation of a bacterial LRRK2 homolog using allosteric nanobodies

  2024cites this paper
• Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism

  2024cites this paper
• LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting.

  2024cites this paper
• Clinical characteristics and pathophysiological properties of newly discovered LRRK2 variants associated with Parkinson's disease.

  2024cites this paper
• Structural insights in the GTP-driven monomerization and activation of a bacterial LRRK2 homologue using allosteric nanobodies

  2024cites this paper
• The Development and Design Strategy of Leucine-Rich Repeat Kinase 2 Inhibitors: Promising Therapeutic Agents for Parkinson's Disease.

  2023cites this paper
• Capturing the domain crosstalk in full length LRRK2 and LRRK2RCKW

  2023cites this paper
• LRRK2 Structure-Based Activation Mechanism and Pathogenesis

  2023cites this paper
• Roc, the G-domain of the Parkinson's disease-associated protein LRRK2.

  2022cites this paper
• The Roc domain of LRRK2 as a hub for protein-protein interactions: a focus on PAK6 and its impact on RAB phosphorylation.

  2022cites this paper
• Leucine rich repeat kinase 2 (LRRK2) peptide modulators: Recent advances and future directions

  2021cites this paper
• LRRK2 Targeting Strategies as Potential Treatment of Parkinson’s Disease

  2021cites this paper
• Using Dictyostelium to Develop Therapeutics for Acute Respiratory Distress Syndrome

  2021cites this paper
• Structural Biology of LRRK2 and its Interaction with Microtubules

  2021cites this paper
• From structure to ætiology: a new window on the biology of leucine-rich repeat kinase 2 and Parkinson's disease

  2021cites this paper
• The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play

  2021cites this paper
• Structural analysis of the full-length human LRRK2.

  2021cites this paper
• Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction

  2020cites this paper
• A novel homozygous LRRK1 stop gain mutation in a patient suspected with osteosclerotic metaphyseal dysplasia

  2020cites this paper
• Parkinson’s Disease-linked LRRK2 structure and model for microtubule interaction

  2020cites this paper
• Structure of LRRK2 in Parkinson’s disease and model for microtubule interaction

  2020cites this paper
• Allosteric modulation of the GTPase activity of a bacterial LRRK2 homolog by conformation-specific Nanobodies

  2020cites this paper
• Highly regulated, diversifying NTP-dependent biological conflict systems with implications for the emergence of multicellularity

  2020cites this paper
• Vesicular Dysfunction and the Pathogenesis of Parkinson’s Disease: Clues From Genetic Studies

  2020cites this paper
• Genetic and Environmental Factors Influence the Pleomorphy of LRRK2 Parkinsonism

  2020cites this paper
• Allosteric inhibition of LRRK2, where are we now

  2020cites this paper
• Structure and nucleotide-induced conformational dynamics of the Chlorobium tepidum Roco protein.

  2019cites this paper
• Roco Proteins: GTPases with a Baroque Structure and Mechanism

  2019influential citation
• Crystal structure of the WD40 domain dimer of LRRK2

  2019cites this paper
• Kinase activity of mutant LRRK2 manifests differently in hetero-dimeric vs. homo-dimeric complexes.

  2019cites this paper
• Parkinson's disease-associated mutations in the GTPase domain of LRRK2 impair its nucleotide-dependent conformational dynamics

  2019cites this paper
• Parkinson's Disease

  2019cites this paper
• Inhibitory role of peroxiredoxin 2 in LRRK2 kinase activity induced cellular pathogenesis.

  2019cites this paper
• Neuroinflammation and Parkinson’s Disease: Understanding the Inflammatory Process Induced by Chronic Peripheral Injection of LPS in LRRK2 G2019S KI Mice in Correlation with Age

  2019cites this paper
• Structural aspects of the regulation of Parkinson's Disease-associated LRRK2 Kinase by Rab GTPases

  2019cites this paper
• The in situ structure of Parkinson’s disease-linked LRRK2

  2019cites this paper
• LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same

  2019cites this paper
• Structure and Function of the G Domain of Parkinson's Disease-Associated Protein LRRK2

  2019cites this paper
• Brussel Structure and nucleotide-induced conformational dynamics of the Chlorobium tepidum

  2019cites this paper
• Activation Mechanism of LRRK 2 and Its Cellular Functions in Parkinson ' s Disease

  2019cites this paper
• LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?

  2019cites this paper
• Crystal structure of LRRK2 WD40 domain dimer

  2019cites this paper
• University of Dundee Crystal structure of the WD 40 domain dimer of LRRK 2

  2019cites this paper
• Structural and biochemical characterization of Roco proteins

  2018influential citation
• P62/SQSTM1 is a novel leucine-rich repeat kinase 2 (LRRK2) substrate that enhances neuronal toxicity.

  2018cites this paper
• Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK2

  2018cites this paper
• Structural insights into the Roco G-protein cycle

  2018influential citation
• The role of LRRK2 in cytoskeletal dynamics.

  2018cites this paper
• Roco Proteins and the Parkinson’s Disease-Associated LRRK2

  2018influential citation
• Regulation of LRRK2 activation, localization and dimerization

  2018influential citation
• All outputs in CentAUR are protected by Intellectual Property

  2018cites this paper
• Regulation of LRRK2: insights from structural and biochemical analysis

  2018cites this paper
• Chapter 7 The Potential of Targeting LRRK 2 in Parkinson ’ s Disease

  2018influential citation
• Leucine-Rich Repeat Kinase 2 in Parkinson’s Disease: Updated from Pathogenesis to Potential Therapeutic Target

  2018cites this paper
• LRRK 2 gene mutations in the pathophysiology of the ROCO domain and therapeutic targets for Parkinson’s disease: a review

  2018cites this paper
• Biochemical and kinetic properties of the complex Roco G-protein cycle

  2018cites this paper
• The Parkinson's disease–associated mutation N1437H impairs conformational dynamics in the G domain of LRRK2

  2018cites this paper
• The Roc‐COR tandem domain of leucine‐rich repeat kinase 2 forms dimers and exhibits conventional Ras‐like GTPase properties

  2018influential citation
• A homologue of the Parkinson ' s disease-associated protein LRRK 2 undergoes a monomer-dimer transition during GTP

  2017influential citation
• A homologue of the Parkinson’s disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover

  2017influential citation
• The LRR-Roc-COR module of the Chlorobium tepidum Roco protein: crystallization and X-ray crystallographic analysis.

  2017cites this paper
• Molecular Insights and Functional Implication of LRRK2 Dimerization.

  2017cites this paper
• Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity.

  2017influential citation
• Development of LRRK2 Inhibitors for the Treatment of Parkinson's Disease.

  2017cites this paper
• Analysis of lrrk2 towards understanding the pathogenic mechanisms underlying parkinson's disease: deregulated autophagy and endocytosis

  2017cites this paper
• LRRK2 and Parkinson's Disease: From Lack of Structure to Gain of Function.

  2017cites this paper
• GTP binding controls complex formation by the human ROCO protein

  2017cites this paper
• The R 1441 C mutation alters the folding properties of the ROC domain of LRRK 2

  2017cites this paper
• Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation.

  2017cites this paper
• The Potential of Targeting LRRK 2 in Parkinson ’ s Disease

  2017influential citation
• Cryo-EM analysis of homodimeric full-length LRRK2 and LRRK1 protein complexes

  2017cites this paper
• Structural insights obtained for homodimeric full-length LRRK2/LRRK1 protein complexes and liposomal preparation as a tool to study membrane proteins under buffer gradients by Cryo-EM

  2017influential citation
• LRRK2 autophosphorylation enhances its GTPase activity

  2016cites this paper
• Parkinson’s Disease-Associated Mutations Affect Mitochondrial Function

  2016cites this paper
• Structural model of the dimeric Parkinson’s protein LRRK2 reveals a compact architecture involving distant interdomain contacts

  2016influential citation
• Novel LRRK2 substrates at the presynaptic site in vesicle recycling pathways in Parkinson's disease

  2016influential citation
• Endolysosomal Dysfunction in Parkinson Disease: The Role of Disease Mutations in ATP13A2 and LRRK2.

  2016cites this paper
• Identification of protein phosphatase 2A as an interacting protein of leucine-rich repeat kinase 2

  2016cites this paper
• L'RRK de Triomphe: a solution for LRRK2 GTPase activity?

  2016influential citation
• First model of dimeric LRRK2: the challenge of unrevealing the structure of a multidomain Parkinson's-associated protein.

  2016cites this paper
• Structure, function, and leucine-rich repeat kinase 2: On the importance of reproducibility in understanding Parkinson’s disease

  2016cites this paper
• Activation Mechanism of LRRK2 and Its Cellular Functions in Parkinson's Disease

  2016cites this paper
• LRRK 2 : an nence grise of Wnt-mediated neurogenesis ?

  2016cites this paper
• LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?

  2016cites this paper
• The unconventional G-protein cycle of LRRK2 and Roco proteins.

  2016cites this paper
• Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity

  2016influential citation
• Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity

  2016cites this paper
• Revisiting the Roco G-protein cycle.

  2015cites this paper
• LRRK2 Pathways Leading to Neurodegeneration

  2015cites this paper
• Zebrafish as a translational model of Parkinson's disease : a study of microRNAs

  2015cites this paper
• Structural Characterization of LRRK2 Inhibitors.

  2015cites this paper
• Altered motor phenotype and dopamine transmission associated with mutations of the parkinsonian gene LRRK2

  2015influential citation
• Conformational heterogeneity of the Roc domains in C. tepidum Roc–COR and implications for human LRRK2 Parkinson mutations

  2015cites this paper
• Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors

  2014influential citation
• Evolution and Diversity of the Ras Superfamily of Small GTPases in Prokaryotes

  2014cites this paper
• LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis.

  2014influential citation